Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000804:Angiotensin II / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003864:Depression, Chemical; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011311:Pressoreceptors / Q000187:drug effects; D011433:Propranolol / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D012083:Renin / Q000097:blood; D013268:Stimulation, Chemical; D014655:Vascular Resistance / Q000187:drug effects
D010919:Placebos; D000804:Angiotensin II; D011433:Propranolol; D012083:Renin; D007545:Isoproterenol